Dashboard
Flat results in Mar 26
- PAT(Q) At Rs 7.83 cr has Fallen at -14.6% (vs previous 4Q average)
- NET SALES(Q) Lowest at Rs 41.33 cr
- EPS(Q) Lowest at Rs 3.69
Stock is technically in a Mildly Bearish range
With ROE of 23.5, it has a Very Expensive valuation with a 12.4 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0% of the company
Stock DNA
Aerospace & Defense
INR 1,990 Cr (Small Cap)
53.00
37
0.26%
-0.22
24.90%
12.56
Total Returns (Price + Dividend) 
Latest dividend: 2.4 per share ex-dividend date: Jul-02-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Sika Interplant Systems Ltd Hits Intraday Low Amid Price Pressure
Sika Interplant Systems Ltd experienced a significant intraday decline on 11 May 2026, touching a low of Rs 980.05, down 15.64% from the previous close. The stock underperformed its sector and the broader market amid heightened volatility and negative market sentiment.
Read MoreAre Sika Interplant Systems Ltd latest results good or bad?
Sika Interplant Systems Ltd's latest financial results for the quarter ending March 2026 present a mixed picture. The company reported net sales of ₹41.33 crore, which reflects a significant sequential decline of 17.85% from the previous quarter and a year-on-year contraction of 10.19%. This marks the lowest sales figure in the past seven quarters, raising concerns about the timing of order execution and potential project delays within the aerospace and defence sector. In terms of profitability, net profit for the same quarter was ₹7.83 crore, down 17.49% quarter-on-quarter and slightly lower by 1.01% year-on-year. This decline in profit has sparked questions regarding the sustainability of earnings and order visibility moving forward. Despite these revenue and profit declines, Sika Interplant demonstrated resilience in its operating margins, which improved to 25.21%, up from 23.04% in the previous quarte...
Read More Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
05-Jun-2026 | Source : BSECompliances-Certificate under Reg. 74(5) of SEBI (DP)Regulations2018
Compliances-Reg.24(A)-Annual Secretarial Compliance
29-May-2026 | Source : BSECompliances - Reg.24(A)- Annual Secretarial Compliance
Announcement under Regulation 30 (LODR)-Newspaper Publication
11-May-2026 | Source : BSENewspaper Publication
Corporate Actions 
No Upcoming Board Meetings
Sika Interplant Systems Ltd has declared 120% dividend, ex-date: 02 Jul 25
Sika Interplant Systems Ltd has announced 2:10 stock split, ex-date: 17 Mar 25
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 3 FIIs (3.21%)
Ultraweld Engineers Llp (70.1%)
Rimo Capital Fund Lp (2.8%)
20.31%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is -17.85% vs -2.46% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -17.49% vs 6.15% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 87.86% vs 48.46% in Sep 2024
Growth in half year ended Sep 2025 is 76.31% vs 26.02% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 67.16% vs 47.56% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 59.00% vs 34.83% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 43.05% vs 39.26% in Mar 2025
YoY Growth in year ended Mar 2026 is 43.80% vs 30.28% in Mar 2025
